OR

349.7

-0.43%↓

B.US

40.78

+6.34%↑

ASM

638.8

+1.75%↑

IAG.ES

4.02

-0.25%↓

SY1

73.18

-1.48%↓

OR

349.7

-0.43%↓

B.US

40.78

+6.34%↑

ASM

638.8

+1.75%↑

IAG.ES

4.02

-0.25%↓

SY1

73.18

-1.48%↓

OR

349.7

-0.43%↓

B.US

40.78

+6.34%↑

ASM

638.8

+1.75%↑

IAG.ES

4.02

-0.25%↓

SY1

73.18

-1.48%↓

OR

349.7

-0.43%↓

B.US

40.78

+6.34%↑

ASM

638.8

+1.75%↑

IAG.ES

4.02

-0.25%↓

SY1

73.18

-1.48%↓

OR

349.7

-0.43%↓

B.US

40.78

+6.34%↑

ASM

638.8

+1.75%↑

IAG.ES

4.02

-0.25%↓

SY1

73.18

-1.48%↓

Search

UPM-Kymmene Oyj

Fechado

26.74 1.94

Visão Geral

Variação de preço das ações

24h

Atual

Mín

26.23

Máximo

26.95

Indicadores-chave

By Trading Economics

Rendimento

241M

257M

Vendas

14M

2.3B

P/E

Médio do Setor

28.791

32.671

EPS

0.57

Rendimento de Dividendos

5.79

Margem de lucro

11.116

Funcionários

14,624

EBITDA

435M

614M

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

5.79%

3.04%

Próximos Ganhos

29 de abr. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

1.4B

14B

Abertura anterior

24.8

Fecho anterior

26.74

UPM-Kymmene Oyj Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

31 de mar. de 2026, 23:31 UTC

Ações em Alta

Stocks to Watch: Nike, RH, NCino

31 de mar. de 2026, 22:35 UTC

Ganhos

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 de abr. de 2026, 00:00 UTC

Aquisições, Fusões, Aquisições de Empresas

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 de mar. de 2026, 23:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 de mar. de 2026, 23:43 UTC

Conversa de Mercado

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 de mar. de 2026, 23:33 UTC

Conversa de Mercado
Notícias Principais

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 de mar. de 2026, 23:21 UTC

Ganhos

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 de mar. de 2026, 23:14 UTC

Conversa de Mercado
Ganhos

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 de mar. de 2026, 23:12 UTC

Conversa de Mercado

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 de mar. de 2026, 22:36 UTC

Ganhos

China Vanke 2025 Loss Widens >000002.SZ

31 de mar. de 2026, 22:36 UTC

Ganhos

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 de mar. de 2026, 22:36 UTC

Ganhos

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 de mar. de 2026, 22:36 UTC

Ganhos

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 de mar. de 2026, 22:36 UTC

Ganhos

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 de mar. de 2026, 21:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 de mar. de 2026, 21:36 UTC

Conversa de Mercado

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 de mar. de 2026, 21:35 UTC

Ganhos

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 de mar. de 2026, 21:35 UTC

Ganhos

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 de mar. de 2026, 21:35 UTC

Ganhos

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 de mar. de 2026, 21:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 de mar. de 2026, 21:33 UTC

Ganhos

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 de mar. de 2026, 21:32 UTC

Ganhos

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 de mar. de 2026, 21:28 UTC

Ganhos

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 de mar. de 2026, 21:26 UTC

Ganhos

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 de mar. de 2026, 21:25 UTC

Ganhos

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 de mar. de 2026, 21:24 UTC

Conversa de Mercado
Ganhos

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 de mar. de 2026, 21:22 UTC

Ganhos

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 de mar. de 2026, 21:22 UTC

Ganhos

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 de mar. de 2026, 21:21 UTC

Ganhos

Nike's Digital Channel Still Too Promotional, CFO Says

31 de mar. de 2026, 21:20 UTC

Ganhos

Nike CEO: Converse Remains Important to Portfolio

Comparação entre Pares

Variação de preço

UPM-Kymmene Oyj Previsão

Informação Financeira

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre UPM-Kymmene Oyj

UPM-Kymmene Oyj, together with its subsidiaries, engages in the forest-based bioindustry in Europe, North America, Asia, and internationally. It operates through UPM Fibres, UPM Energy, UPM Raflatac, UPM Specialty Papers, UPM Communication Papers, UPM Plywood, and Other Operations segments. The company provides softwood, birch, and eucalyptus pulp for tissue, specialty, and graphic papers and packaging; sawn timber for joinery, packaging, furniture, planning, and construction industries; and wood-based renewable diesel and renewable naphtha for transport and petrochemical industry. It is also involved in the generation of electricity through hydro, thermal, and nuclear power plants. In addition, the company offers self-adhesive label materials for branding and promotion, information, and functional labeling in the food, beverage, personal care, pharmaceutical, and logistics segments; and specialty packaging materials, such as label papers, release liners, office papers, and flexible packaging for labeling, packing, commercial siliconizing, and printing, as well as graphic papers for advertising, publishing, and home and office use. Further, it provides plywood and veneer products for construction, vehicle flooring, liquefied natural gas shipbuilding, and parquet manufacturing, as well as for other industrial applications; wood and wood-based biomass, and forestry services for forest investors and owners; wood-based biomedical products, such as nano-fibrillar cellulose for clinical and life science applications; wood-based lignin products for industrial use; and UPM ProFi decking products and UPM formi granules. Additionally, the company offers financial portfolio management services. UPM-Kymmene Oyj was founded in 1871 and is headquartered in Helsinki, Finland.
help-icon Live chat